Pharma Mar | PHM - Net Income

Stock Price
76.95
Daily Change
-0.20 -0.26%
Monthly
0.26%
Yearly
-16.04%
Q1 Forecast
76.83

Pharma Mar reported EUR-4.1M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Almirall EUR 26.58M 31.82M Jun/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Pharma Mar EUR -4.1M 27.47M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025